AM6545
SIGMA/A1987 - ≥98% (HPLC)
Synonym: 5-
CAS Number: 1245626-05-4
Empirical Formula (Hill Notation): C26H23Cl2N5O3S
Molecular Weight: 556.46
MDL Number: MFCD19053178
Linear Formula: C26H23Cl2N5O3S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to off-white |
| form | powder |
| InChI | 1S/C26H23Cl2N5O3S/c1-18-2 |
| InChI key | XBHQLFVDGLPBCK-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Cc1c(nn(-c2ccc(Cl)cc2Cl)c |
| solubility | DMSO: >25 mg/mL |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | AM6545 helps in decreasing the development of albuminuria, inflammation and expression of markers of fibrosis. It also helps in the down-regulation of nephrin and podocin. It has the ability to repress the ingestion of food and food-reinforced behaviour. |
| Biochem/physiol Actions: | AM6545 is a peripheral CB1 cannabinoid receptor antagonist and appetite suppressant. |
| Features and Benefits: | This compound is featured on the Cannabinoid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| General description: | AM6545 is a cannabinoid (CB1) receptor antagonist. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H319 |
| Precautionary statements | P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36 |
| Safety Statements | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


